Archford Capital Strategies LLC raised its stake in Visa Inc. by 1.1% in the second quarter of 2025, purchasing an additional 496 shares. This move brings the fund’s total Visa holdings to 46,884 shares, according to its latest SEC filing.
Visa Inc. $V Holdings Lifted by Archford Capital Strategies LLC

Key Takeaways:
- Archford Capital Strategies LLC increased its stake in Visa Inc. by 1.1%.
- The firm purchased an additional 496 shares.
- It now owns a total of 46,884 Visa shares.
- The details come from its second-quarter 13F filing with the SEC.
- Visa remains a leading credit-card processor.
Archford Increases Investment
Archford Capital Strategies LLC added to its Visa Inc. holdings during the second quarter of 2025, as highlighted in the firm’s recent 13F filing with the Securities and Exchange Commission (SEC). The additional 496 shares represent a 1.1% increase in Archford’s overall stake, underlining the firm’s steady confidence in the global credit-card processor.
SEC Filing Details
The investment, revealed in the official second-quarter report, pushes the total share count owned by Archford Capital Strategies LLC to 46,884. Such filings are routinely monitored by market analysts seeking to track major shareholders’ changing sentiment and investment strategies.
Visa’s Role as a Leading Processor
Visa Inc. stands among the foremost credit-card networks in business worldwide. Its shares continue to be a focal point for institutional investors like Archford Capital Strategies LLC, which follows the company’s performance closely. Although the filing did not include broader commentary on the reasons behind the addition, it underscores a continued commitment to Visa’s potential trajectory.
Significance of Regulatory Data
Regulatory filings, such as this 13F document, provide transparency into investment managers’ positions and can offer valuable insights into where funds are placing their confidence. In this case, the incremental bump in shares, although modest, signals ongoing interest in Visa’s market performance and long-term outlook.